The signal pathways and treatment of cytokine storm in COVID-19

L Yang, X Xie, Z Tu, J Fu, D Xu, Y Zhou - Signal transduction and …, 2021 - nature.com
Abstract The Coronavirus Disease 2019 (COVID-19) pandemic has become a global crisis
and is more devastating than any other previous infectious disease. It has affected a …

Role of JAK/STAT in interstitial lung diseases; molecular and cellular mechanisms

P Montero, J Milara, I Roger, J Cortijo - International journal of molecular …, 2021 - mdpi.com
Interstitial lung diseases (ILDs) comprise different fibrotic lung disorders characterized by
cellular proliferation, interstitial inflammation, and fibrosis. The JAK/STAT molecular pathway …

[HTML][HTML] COVCOG 2: cognitive and memory deficits in long COVID: a second publication from the COVID and cognition study

P Guo, A Benito Ballesteros, SP Yeung… - Frontiers in aging …, 2022 - frontiersin.org
COVID-19, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has
been often characterized as a respiratory disease. However, it is increasingly being …

COVID-19 infection: an overview on cytokine storm and related interventions

S Montazersaheb, SM Hosseiniyan Khatibi, MS Hejazi… - Virology journal, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) has posed a significant threat to global health. This …

Inhaled vaccine delivery in the combat against respiratory viruses: a 2021 overview of recent developments and implications for COVID-19

R Heida, WLJ Hinrichs, HW Frijlink - Expert review of vaccines, 2022 - Taylor & Francis
Introduction As underlined by the late 2019 outbreak of severe acute respiratory syndrome-
coronavirus-2 (SARS-CoV-2), vaccination remains the cornerstone of global health-care …

Association between IL-6 and severe disease and mortality in COVID-19 disease: a systematic review and meta-analysis

X Liu, H Wang, S Shi, J Xiao - Postgraduate medical journal, 2022 - academic.oup.com
Abstract Background So far, SARS-CoV-2 is the seventh coronavirus found to infect humans
and cause disease with quite a strong infectivity. Patients diagnosed as severe or critical …

A review on possible mechanistic insights of Nitazoxanide for repurposing in COVID-19

AS Lokhande, PV Devarajan - European Journal of Pharmacology, 2021 - Elsevier
The global pandemic of Coronavirus Disease 2019 (COVID-19) has brought the world to a
grinding halt. A major cause of concern is the respiratory distress associated mortality …

Vascular dysfunction of COVID-19 is partially reverted in the long-term

L Zanoli, A Gaudio, DP Mikhailidis, N Katsiki… - Circulation …, 2022 - Am Heart Assoc
Background: COVID-19 is characterized by severe inflammation during the acute phase and
increased aortic stiffness in the early postacute phase. In other models, aortic stiffness is …

[HTML][HTML] COVID-19 a triggering factor of autoimmune and multi-inflammatory diseases

EK Sher, A Ćosović, A Džidić-Krivić, EK Farhat, E Pinjić… - Life sciences, 2023 - Elsevier
SARS-Cov-2 virus has attracted a lot of attention globally, due to the autoimmune and
inflammatory processes that were observed during the development of Covid-19 disease …

Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response

L Pearce, SM Davidson, DM Yellon - Basic research in cardiology, 2021 - Springer
The benefits of remote ischaemic conditioning (RIC) have been difficult to translate to
humans, when considering traditional outcome measures, such as mortality and heart …